UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients
|ClinicalTrials.gov Identifier: NCT01622595|
Recruitment Status : Withdrawn (Principal Investigator has left the institution.)
First Posted : June 19, 2012
Last Update Posted : October 27, 2015
|Condition or disease|
|Aspergillosis Candidemia C. Difficile|
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||A Non-interventional Observational Study of Infectious Complications in Cancer Patients|
|Study Start Date :||November 2009|
|Estimated Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||December 2015|
- To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients [ Time Frame: 3 years ]To study the incidence, risk factors, clinical presentation, diagnosis and prognostic factors of infectious complications in cancer patients
- incidence [ Time Frame: 3 years ]
To determine the overall incidence of different infections, including bacterial, fungal and viral infections in cancer patients receiving chemotherapy and / or hematopoietic stem cell transplantation.
- To describe the natural history of such infections in cancer patients.
- To monitor the adherence of Myeloma institute for research and therapy(MIRT) health care workers to the MIRT standard operational procedures (SOPs)
- To identify risk factors for the development of specific infections.
- To validate surrogate markers as early diagnostic tools for various infections.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01622595
|United States, Arkansas|
|University of Arkansas for Medical Sciences|
|Little Rock, Arkansas, United States, 72205|
|Principal Investigator:||Senu Apewokin, MD||UAMS|